Materials and Methods Post-bariatric patients without type 2 diabetes (T2D) with WR or IWL ( n = 44) were included in the analysis
Gastroparesis, also known as stomach paralysis, is a condition in which the stomach empties very slowly
Semaglutide works by decreasing appetite, which can lead to reduced calorie intake and subsequent weight loss
SomaScan proteomic profiling and SomaSignal NASH tests in participants with biopsy-confirmed MASH Serum samples for future use were obtained at four timepoints in the phase 2 trial: at baseline and after 28, 52 and 72 weeks of treatment
How semaglutide affects less common blood markers Beyond the standard panels, semaglutide influences several markers that may appear on specialized or expanded blood work
"It's amazing, everybody should try it if they're trying to lose weight," Wood said